DrugPatentWatch Week in Review

FEATURED ARTICLE Branded Generics Promise Profits for Drugmakers, Peace of Mind for Patients Developing nations offer welcoming and growing markets as Abbott focuses exclusively on reformulating and marketing off-patent medications Read more » See What Others Are Saying About DrugPatentWatch: RECENTLY REGISTERED 505(b)(2) TRIALS 505(b)(2)’s are a hybrid between a branded drug application and a […] Source